title: Letter regarding article by Hlatky et al, "medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease".
authors.forename: Faizel
authors.initials: F
authors.lastname: Osman
authors.forename: Sohail
authors.initials: S
authors.lastname: Qaisar
authors.forename: Michael
authors.initials: M
authors.lastname: Pitt
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease / Q000191:economics / Q000628:therapy*; D017048:Health Care Costs; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D015607:Stents
chemical_list: D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex